Many deals reflected the industry’s affinity for robotics. Mobius Imaging complements Stryker’s implant and navigation products, and also supports the Spine division’s foray into the intra-operative imaging market. Smith+Nephew, meanwhile, intends to use Atracsys Sarl’s optical tracking camera fusionTrack 500 in its next-generation robotics platform. Compared to existing tracking technology, fusionTrack 500 is said to offer a better measurement speed and latency performance, reduced procedure times, and increased accuracy for finer surgical tasks such as bone cuts. Smith+Nephew also bought Brainlab’s orthopedic joint reconstruction business last spring to bolster its multi-asset digital surgery and robotic technologies offerings. “This partnership with Brainlab is a critical driver of our digital surgery and robotic ecosystem,” Namal Nawana, former Smith+Nephew CEO, said of the deal.
We hope you enjoy reading this year’s Top 10 report.
Editors’ note: As you read our report, please take note that while the companies are ranked according to sales reported for their most recent fiscal year, some may include non-device sales within a division, such as combination products, drug delivery, software, or device-related services. Not all companies explicitly break out the device portion of total revenues. We consulted numerous public documents and contacted company officials as needed to arrive at the best estimates.
TOP ORTHOPEDIC DEVICE FIRMS
|2. DePuy Synthes||$8.84B|
|3. Zimmer Biomet||$7.98B|
|4. Smith & Nephew||$5.13B|
|5. Medtronic Spine||$2.50B|
|8. Globus Medical||$785M|
|10. Integra LifeSciences||$521M|